# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-014549
Filing Date
2021-04-27
Accepted
2021-04-27 16:19:13
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | nc10021408x2_defa14a.htm | DEFA14A | 17508
2 |  | nc10021408x2_nc01.jpg | GRAPHIC | 764775
3 |  | nc10021408x2_nc02.jpg | GRAPHIC | 446601
| Complete submission text file | 0001140361-21-014549.txt |  | 1647077

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 21859184
SIC: 2834 Pharmaceutical Preparations